State of Wisconsin Investment Board
PSTX

State of Wisconsin Investment Board’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

State of Wisconsin Investment Board’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-55,700
Closed -$535K – 2382
2024
Q4 		$535K Buy
+55,700
New +$291K ﹤0.01% 1778
2023
Q2 		– Sell
-43,579
Closed -$134K – 2572
2023
Q1 		$134K Buy
+43,579
New +$261K ﹤0.01% 2344
2022
Q3 		– Sell
-24,322
Closed -$63K – 2803
2022
Q2 		$63K Sell
24,322
-15,678
-39% -$43.6K ﹤0.01% 2682
2022
Q1 		$179K Buy
+40,000
New +$180K ﹤0.01% 2194
2021
Q4 		– Sell
-18,800
Closed -$137K – 2228
2021
Q3 		$137K Hold
18,800
– – ﹤0.01% 2094
2021
Q2 		$188K Hold
18,800
– – ﹤0.01% 2038
2021
Q1 		$180K Hold
18,800
– – ﹤0.01% 2002
2020
Q4 		$206K Buy
+18,800
New +$198K ﹤0.01% 1945

Other funds holding PSTX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

State of Wisconsin Investment Board's PSTX Position: Q1 2025 in Review

State of Wisconsin Investment Board sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 55,700 shares — an estimated $535K sold.

State of Wisconsin Investment Board first reported a position in PSTX in Q4 2020 and held it in 8 quarters. The position peaked at $535K in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

  • State of Wisconsin Investment Board reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 55,700 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $535K.
  • State of Wisconsin Investment Board first reported a position in Poseida Therapeutics, Inc. Common Stock in Q4 2020 and held it in 8 quarters.
  • State of Wisconsin Investment Board's Poseida Therapeutics, Inc. Common Stock position peaked at $535K in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2025, filed 15 May 2025.